Janux Therapeutics Inc (JANX)
$17.47 -2.02% Close Oct 30, 2026 Live
Janux Therapeutics stock today
Janux Therapeutics closed at $17.47 on October 30, 2026, down 2.02% on the day. Over the past year it returned -38.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.06 billion.
$20.00$30.00
NovJan 2026MarMayJulSep
| Period | JANX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.1% | -0.9% |
| 3 months | +12.1% | +2.1% |
| Year to date | +26.6% | +11.7% |
| 1 year | -38.7% | +12.4% |
| 3 years | +185.0% | +88.5% |
| 5 years | -28.3% | +76.0% |
Key statistics
- Market value
- $1.06B
- Price / sales
- 44.4
- 52-week range
- $12.18 to $34.74
- Next report
- Nov 5, 2026 (estimated)
About Janux Therapeutics
Develops T-cell engager immunotherapies for cancer treatment.
Sector: Health Care
More on Janux Therapeutics
- Financials: revenue, earnings and segmentsRevenue -6% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $717.45 today
No forecast, no recommendation. This page describes Janux Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.